Key Tronic (KTCC) 10-Q 8 May 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Mar. 29, 2014	Apr. 25, 2014
Document Documentand Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	29-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'ktcc	'
Entity Registrant Name	'KEY TRONIC CORP	'
Entity Central Index Key	'0000719733	'
Current Fiscal Year End Date	'--06-28	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	10,539,503

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 29, 2014	Jun. 29, 2013
In Thousands, unless otherwise specified
ASSETS	'	'
Cash and cash equivalents	$2,241	$10,819
Trade receivables, net of allowances of $37 and $40, respectively	52,637	47,009
Inventories	46,086	44,664
Deferred income tax asset	1,516	1,767
Other	9,464	7,508
Total current assets	111,944	111,767
Property, plant and equipment—net	21,188	17,911
Other assets:	'	'
Deferred income tax asset	3,052	3,179
Other	1,914	2,273
Goodwill	1,740	0
Other intangible assets	2,138	0
Total other assets	8,844	5,452
Total assets	141,976	135,130
LIABILITIES AND SHAREHOLDERS' EQUITY	'	'
Accounts payable	28,540	26,400
Accrued compensation and vacation	6,297	7,413
Current portion of other long-term obligations	0	576
Other	5,021	3,551
Total current liabilities	39,858	37,940
Long-term liabilities:	'	'
Deferred income tax liability	0	1,585
Other long-term obligations	564	1,445
Total long-term liabilities	564	3,030
Total liabilities	40,422	40,970
Commitments and contingencies (Note 8)	'	'
Shareholders’ equity:	'	'
Common stock, no par value—shares authorized 25,000; issued and outstanding 10,533 and 10,502 shares, respectively	44,015	43,369
Retained earnings	55,711	49,478
Accumulated other comprehensive income	1,828	1,313
Total shareholders’ equity	101,554	94,160
Total liabilities and shareholders’ equity	$141,976	$135,130

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 29, 2014	Jun. 29, 2013
In Thousands, except Per Share data, unless otherwise specified
Statement of Financial Position [Abstract]	'	'
Allowance for Doubtful Accounts Receivable, Current	$40	$37
Common stock - par value	$0	$0
Common stock - shares authorized	25,000	25,000
Common stock - shares issued	10,533	10,502
Common stock - shares outstanding	10,533	10,502

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Income Statement [Abstract]	'	'	'	'
Net sales	$77,043	$84,343	$233,267	$276,418
Cost of sales	70,436	76,483	213,088	249,587
Gross profit	6,607	7,860	20,179	26,831
Operating expenses	'	'	'	'
Research, development and engineering expenses	1,414	1,329	4,181	3,804
Selling, general and administrative expenses	2,985	2,938	8,964	8,406
Total operating expenses	4,399	4,267	13,145	12,210
Operating income	2,208	3,593	7,034	14,621
Interest expense, net	12	38	50	246
Income before income taxes	2,196	3,555	6,984	14,375
Income tax provision	782	692	751	4,189
Net income	$1,414	$2,863	$6,233	$10,186
Earnings per share:	'	'	'	'
Net income per share — Basic (in dollars per share)	$0.13	$0.27	$0.59	$0.97
Weighted average shares outstanding — Basic	10,533	10,489	10,523	10,488
Net income per share — Diluted (in dollars per share)	$0.13	$0.26	$0.57	$0.94
Weighted average shares outstanding — Diluted	10,926	10,931	10,920	10,888

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Comprehensive income:	'	'	'	'
Net income	$1,414	$2,863	$6,233	$10,186
Other comprehensive income:	'	'	'	'
Unrealized gain on foreign exchange contracts, net of tax	203	2,458	515	3,481
Comprehensive income	$1,617	$5,321	$6,748	$13,667

CONSOLIDATED_STATEMENTS_OF_COM1

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Unrealized gain (loss) on foreign exchange contracts, tax	$0.10	$1.30	$0.30	$1.80

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
Operating activities:	'	'
Net income	$6,233	$10,186
Adjustments to reconcile net income to cash provided by operating activities:	'	'
Depreciation and amortization	2,792	1,955
Excess tax benefit from exercise of stock options	-113	-103
Provision for obsolete inventory	227	422
Provision for warranty	19	16
Provision for doubtful accounts	37	62
Gain (Loss) on Disposition of Assets	10	27
Share-based compensation expense	483	647
Deferred income taxes	-1,532	1,495
Changes in operating assets and liabilities:	'	'
Trade receivables	-5,665	12,212
Inventories	-872	10,274
Other assets	-1,411	-2,199
Accounts payable	2,140	-15,741
Accrued compensation and vacation	-1,116	460
Other liabilities	1,120	1,127
Cash provided by operating activities	2,352	20,840
Investing activities:	'	'
Payment for acquisition	-6,027	0
Proceeds from Life Insurance Policies	0	144
Purchase of property and equipment	-4,467	-2,768
Cash used in investing activities	-10,494	-2,624
Financing activities:	'	'
Payments of Financing Costs	-23	-75
Principal payments on capital lease obligations	-576	-542
Borrowings under revolving credit agreement	0	66,528
Repayment of revolving credit agreement	0	-81,539
Excess tax benefit from exercise of stock options	113	103
Proceeds from exercise of stock options	50	9
Cash used in financing activities	-436	-15,516
Net (decrease) increase in cash and cash equivalents	-8,578	2,700
Cash and cash equivalents, beginning of period	10,819	502
Cash and cash equivalents, end of period	2,241	3,202
Supplemental cash flow information:	'	'
Interest payments	56	289
Income tax payments, net of refunds	$1,850	$1,781

CONSOLIDATED_STATEMENTS_OF_SHA

CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY (USD $)	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
In Thousands, unless otherwise specified
Balances at Jun. 29, 2013	$94,160	$43,369	$49,478	$1,313
Balances (Shares) at Jun. 29, 2013	'	10,502	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'
Net income	6,233	'	'	'
Unrealized gain on foreign exchange contracts, net	515	'	'	515
Exercise of stock options, (Shares)	'	31	'	'
Exercise of stock options	50	50	'	'
Share-based compensation	483	483	'	'
Tax benefit from exercise of stock options	113	113	'	'
Balances at Mar. 29, 2014	$101,554	$44,015	$55,711	$1,828
Balances (Shares) at Mar. 29, 2014	'	10,533	'	'

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Mar. 29, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
BASIS OF PRESENTATION	'
	Basis of Presentation
	The consolidated financial statements included herein have been prepared by Key Tronic Corporation and subsidiaries (the Company) pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in our annual consolidated financial statements have been condensed or omitted. The year-end condensed consolidated balance sheet information was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 29, 2013.
	The Company’s reporting period is a 52/53 week fiscal year ending on the Saturday closest to June 30. The three and nine month periods ended March 29, 2014 and March 30, 2013 were 13 week and 39 week periods, respectively. Fiscal year 2014 will end on June 28, 2014 which is a 52 week year, and fiscal year 2013 which ended on June 29, 2013, was also a 52 week year.
Fiscal Year	'
	The Company’s reporting period is a 52/53 week fiscal year ending on the Saturday closest to June 30. The three and nine month periods ended March 29, 2014 and March 30, 2013 were 13 week and 39 week periods, respectively. Fiscal year 2014 will end on June 28, 2014 which is a 52 week year, and fiscal year 2013 which ended on June 29, 2013, was also a 52 week year.

SIGNIFICANT_ACCOUNTING_POLICIE

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Mar. 29, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies	'
	Significant Accounting Policies
	Earnings Per Common Share
	Basic earnings per common share (EPS) is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing net income by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of equity awards were used to repurchase common shares at the average market price during the period. The computation of diluted EPS does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on EPS.
	Derivative Instruments and Hedging Activities
	The Company has entered into foreign currency forward contracts which are accounted for as cash flow hedges in accordance with ASC 815, Derivatives and Hedging. The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative's effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item.
	The Company transacts business in Mexico and is subject to the risk of foreign currency exchange rate fluctuations. The Company enters into foreign currency forward contracts to manage the majority of foreign currency fluctuations for Mexican peso denominated payroll, utility, tax, and accounts payable expenses. The foreign currency forward contracts have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded.
	The Company's foreign currency forward contracts potentially expose the Company to credit risk to the extent the counterparties may be unable to meet the terms of the agreement. The Company minimizes such risk by seeking high quality counterparties. The Company's counterparties to the foreign currency forward contracts are major banking institutions. These institutions do not require collateral for the contracts, and the Company believes that the risk of the counterparties failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes.
	Income Taxes
	We compute our interim income tax provision through the use of an estimated annual effective tax rate (ETR) applied to year-to-date operating results and specific events that are discretely recognized as they occur. In determining the estimated annual ETR, we analyze various factors, including projections of our annual earnings, taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, our ability to use tax credits and net operating loss carryforwards, and available tax planning alternatives. Discrete items, including the effect of changes in tax laws, tax rates, and certain circumstances with respect to valuation allowances or other unusual or non-recurring tax adjustments, are reflected in the period in which they occur as an addition to, or reduction from, the income tax provision, rather than included in the estimated annual ETR. Refer to Note 5 for further discussions.
	Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, as well as operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized.
	We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. To date, we have not incurred charges for interest or penalties in relation to the underpayment of income taxes. The tax years 1998 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject.
	Recently Issued Accounting Standards
	Management has assessed the potential impact of recently issued, but not yet effective, accounting standards and determined that the provisions are either not applicable to the Company, or are not anticipated to have a material impact on the consolidated financial statements.

INVENTORIES

INVENTORIES	9 Months Ended
	Mar. 29, 2014
Inventory Disclosure [Abstract]	'
INVENTORIES	'
	Inventories
	The components of inventories consist of the following (in thousands):
		29-Mar-14		29-Jun-13
	Finished goods	$	5,789	$	7,097
	Work-in-process	5,583		5,098
	Raw materials and supplies	34,714		32,469
		$	46,086	$	44,664

LONGTERM_DEBT

LONG-TERM DEBT	9 Months Ended
	Mar. 29, 2014
Debt Disclosure [Abstract]	'
LONG-TERM DEBT	'
	Long-Term Debt
	On October 15, 2010, the Company entered into an amended credit agreement with Wells Fargo Bank, N.A. thereby increasing its revolving line of credit facility for up to $30.0 million. On November 8, 2013, the Company entered into a third amendment to the credit agreement extending the term to October 15, 2018. The agreement specifies that the proceeds of the revolving line of credit be used primarily for working capital and general corporate purposes of the Company and its subsidiaries. Borrowings under this revolving line of credit bear interest at either a “Base Rate” or a “Fixed Rate”, as elected by the Company. The base rate is the higher of the Wells Fargo Bank prime rate, daily one month London Interbank Offered Rate (LIBOR) plus 1.5%, or the Federal Funds rate plus 1.5%. The fixed rate is LIBOR plus 1.75%, LIBOR plus 2.00%, or LIBOR plus 2.25% depending on the level of the Company’s trailing four quarters Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA). The revolving line of credit is secured by substantially all of the assets of the Company.
	The Company must comply with certain financial covenants, including a cash flow leverage ratio and an asset coverage ratio. The credit agreement requires the Company to maintain a minimum profit threshold, limits the maximum operating lease expenditures and restricts the Company from declaring or paying dividends in cash or stock. The Company is in compliance with all financial covenants for all periods presented.
	As of March 29, 2014, the Company had availability to borrow $30.0 million under the line of credit. The company did not have an outstanding balance on the line of credit as of March 29, 2014 or June 29, 2013.

INCOME_TAXES

INCOME TAXES	9 Months Ended
	Mar. 29, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	Income Taxes
	The Company expects to repatriate a portion of its foreign earnings based on increased sales growth driving additional capital requirements domestically, cash requirements for potential acquisitions and to implement certain tax strategies. The Company currently expects to repatriate approximately $9.9 million of foreign earnings in the future. As such, these earnings would be recognized in the United States, and the Company would be subject to U.S. federal income taxes and potential withholding taxes in foreign jurisdictions. Both the domestic tax and estimated withholding tax of expected repatriation of foreign earnings have been recorded as part of deferred taxes as of March 29, 2014. All other unremitted foreign earnings are expected to remain permanently reinvested for planned fixed assets purchases and improvements in foreign locations.
	Mexican tax reform was signed into law in December 2013 creating a discrete benefit of approximately $1.5 million that was recognized during the second quarter as a result of a change in applicable tax regimes. In recent years, the Company had been subject to a Mexican business flat tax called Impuesto Empresarial a Tasa Unica (IETU). However, effective January 1, 2014, IETU was repealed as part of a larger reform of the Mexican tax system. The Company is now subject to the general Mexican tax regime (ISR). The effective tax rate for the nine months ended March 29, 2014 is based on the anticipated annualized effects of both the IETU and ISR regimes for fiscal year 2014.
	The Company has available approximately $5.0 million of gross federal research and development tax credits as of March 29, 2014. ASC 740 requires the Company to recognize in its financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. Accordingly, as of March 29, 2014, the Company has recorded $3.1 million to date of gross unrecognized tax benefits associated with these federal tax credits, resulting in a net deferred tax benefit of approximately $1.9 million.

EARNINGS_PER_SHARE

EARNINGS PER SHARE	9 Months Ended
	Mar. 29, 2014
Earnings Per Share [Abstract]	'
EARNINGS PER SHARE	'
	Earnings Per Share
	The following table presents a reconciliation of the denominator in the basic and diluted EPS calculation and the number of antidilutive common share awards that were not included in the diluted earnings per share calculation. These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period.
		Three Months Ended
		(in thousands, except per share information)
		March 29, 2014		March 30, 2013
	Net income	$	1,414	$	2,863
	Weighted average shares outstanding—basic	10,533		10,489
	Effect of dilutive common stock options	393		442
	Weighted average shares outstanding—diluted	10,926		10,931
	Earnings per share—basic	$	0.13	$	0.27
	Earnings per share—diluted	$	0.13	$	0.26
	Antidilutive options not included in diluted earnings per share	208		—
		Nine Months Ended
		(in thousands, except per share information)
		March 29, 2014		March 30, 2013
	Net income	$	6,233	$	10,186
	Weighted average shares outstanding—basic	10,523		10,488
	Effect of dilutive common stock options	397		400
	Weighted average shares outstanding—diluted	10,920		10,888
	Earnings per share—basic	$	0.59	$	0.97
	Earnings per share—diluted	$	0.57	$	0.94
	Antidilutive options not included in diluted earnings per share	208		—

SHAREBASED_COMPENSATION

SHARE-BASED COMPENSATION	9 Months Ended
	Mar. 29, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Share-based Compensation
	The Company’s incentive plan provides for equity and liability awards to employees and non-employee directors in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold and selling general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations.
	In addition to service conditions, SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are measured over the vesting period and are charged to compensation expense over the requisite service period based on the number of shares expected to vest. The SARs cliff vest after a three-year period from date of grant and expire five years from date of grant.
	The grant date fair value for the awards granted below were estimated using the Black Scholes option valuation method:
		July 31, 2013		July 25, 2012		January 26, 2012		27-Jul-11
	SARs Granted	213,166		210,666		32,000		184,666
	Strike Price	$	11.34	$	7.44	$	6.3	$	4.4
	Fair Value	$	4.67	$	3.71	$	3.08	$	2.2
	Total share-based compensation expense recognized during the three months ended March 29, 2014 and March 30, 2013 was approximately $148,000 and $222,000, respectively. Total share-based compensation expense recognized during the nine months ended March 29, 2014 and March 30, 2013 was approximately $483,000 and $647,000, respectively. As of March 29, 2014 total unrecognized compensation expense related to unvested share-based compensation arrangements was approximately $1.1 million. This expense is expected to be recognized over a weighted average period of 1.95 years.
	No options to purchase shares of common stock or SARs were exercised during the three months ended March 29, 2014 or the three months ended March 30, 2013. During the nine months ended March 29, 2014, 19,930 options to purchase shares of common stock were exercised and 30,000 SARs were exercised, with an intrinsic value of approximately $0.3 million. Options to purchase 7,500 shares of common stock were exercised during the nine months ended March 30, 2013, with an immaterial amount of intrinsic value.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Mar. 29, 2014
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	Commitments and Contingencies
	Purchase Commitments
	The Company had no material firm commitments to contractors or suppliers for capital expenditures as of March 29, 2014.
	Leases
	The Company leases certain facilities, equipment, and automobiles under non-cancelable lease agreements. These agreements expire on various dates over the next ten years.
	Warranties
	The Company provides warranties on certain product sales. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. If actual return rates and/or repair and replacement costs differ significantly from management’s estimates, adjustments to recognize additional cost of sales may be required in future periods. The Company’s warranty reserve was approximately $8,000 and $9,000 as of March 29, 2014 and June 29, 2013, respectively.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Mar. 29, 2014
Fair Value Disclosures [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	Fair Value Measurements
	The Company has adopted ASC 820, Fair Value Measurements, which defines fair value, establishes a framework for assets and liabilities being measured and reported at fair value and expands disclosures about fair value measurements. There are three levels of fair value hierarchy inputs used to value assets and liabilities which include: Level 1 – inputs are quoted market prices for identical assets or liabilities; Level 2 – inputs other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – inputs are unobservable inputs for the asset or liability.
	The following table summarizes the fair value of assets/(liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of March 29, 2014 and June 29, 2013 (in thousands):
		29-Mar-14
		Level 1		Level 2			Level 3		Total
									Fair Value
	Financial Assets:
	Foreign currency forward contracts	$	—	$	2,833		$	—	$	2,833
	Financial Liabilities:
	Foreign currency forward contracts	$	—	$	(59	)	$	—	$	(59	)
		29-Jun-13
		Level 1		Level 2			Level 3		Total
									Fair Value
	Financial Assets:
	Foreign currency forward contracts	$	—	$	2,429		$	—	$	2,429
	Financial Liabilities:
	Foreign currency forward contracts	$	—	$	(434	)	$	—	$	(434	)
	The Company currently has forward contracts to hedge known future cash outflows for expenses denominated in the Mexican peso. These contracts are measured on a recurring basis based on the foreign currency spot rates and forward rates quoted by banks or foreign currency dealers. These contracts are marked to market using level 2 input criteria every period with the unrealized gain or loss, net of tax, reported as a component of shareholders’ equity in accumulated other comprehensive income, as they qualify for hedge accounting.
	The carrying values of cash and cash equivalents, accounts receivable and current liabilities reflected on the balance sheets at March 29, 2014 and June 29, 2013, reasonably approximate their fair value.

DERIVATIVE_FINANCIAL_INSTRUMEN

DERIVATIVE FINANCIAL INSTRUMENTS	9 Months Ended
	Mar. 29, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
DERIVATIVE FINANCIAL INSTRUMENTS	'
	Derivative Financial Instruments
	As of March 29, 2014, the Company had outstanding foreign currency forward contracts with a total notional amount of $67.4 million. The maturity dates for these contracts extend through June 2017. For the three months ended March 29, 2014, the Company entered into foreign currency forward contracts of $5.0 million and settled $5.7 million of such contracts. For the three months ended March 30, 2013, the Company entered into $10.9 million of foreign currency forward contracts and settled $5.8 million of such contracts.
	For the nine months ended March 29, 2014, the Company entered into forward contracts of $15.2 million and settled $17.6 million of such contracts. During the same period of the previous year, the Company entered into foreign currency forward contracts of $21.5 million and settled $17.0 million of such contracts.
	The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of March 29, 2014 and June 29, 2013 (in thousands):
				29-Mar-14				29-Jun-13
	Derivatives Designated as Hedging Instruments	Balance Sheet Location		Fair Value				Fair Value
	Foreign currency forward contracts	Other current assets		$	2,020			$	760
	Foreign currency forward contracts	Other long-term assets		$	813			$	1,669
	Foreign currency forward contracts	Other current liabilities		$	—			$	(145	)
	Foreign currency forward contracts	Other long-term liabilities		$	(59	)		$	(289	)
	The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended March 29, 2014 and March 30, 2013, respectively (in thousands):
	Derivatives Designated as Hedging Instruments	AOCI Balance				Effective				Effective Portion			AOCI Balance
		as of				Portion				Reclassified From			as of
		December 28,				Recorded In				AOCI Into			March 29,
		2013				AOCI				Cost of  Sales			2014
	Settled foreign currency forward contracts for the three months ended March 29, 2014	$	110			$	11			$	(121	)	$	—
	Unsettled foreign currency forward contracts	1,515				313				—			1,828
	Total	$	1,625			$	324			$	(121	)	$	1,828
	Derivatives Designated as Hedging Instruments	AOCI Balance				Effective				Effective Portion			AOCI Balance
		as of				Portion				Reclassified From			as of March 30,
		December 29,				Recorded In				AOCI Into			2013
		2012				AOCI				Cost of  Sales
	Settled foreign currency forward contracts for the three months ended March 30, 2013	$	(9	)		$	184			$	(175	)	$	—
	Unsettled foreign currency forward contracts	373				2,449				—			2,822
	Total	$	364			$	2,633			$	(175	)	$	2,822
	The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the nine months ended March 29, 2014 and March 30, 2013, respectively (in thousands):
	Derivatives Designated as Hedging Instruments	AOCI Balance				Effective				Effective Portion			AOCI Balance
		as of June 29,				Portion				Reclassified From			as of
		2013				Recorded In				AOCI Into			March 29,
						AOCI				Cost of  Sales			2014
	Settled foreign currency forward contracts for the nine months ended March 29, 2014	$	85			$	124			$	(209	)	$	—
	Unsettled foreign currency forward contracts	1,228				600				—			1,828
	Total	$	1,313			$	724			$	(209	)	$	1,828
	Derivatives Designated as Hedging Instruments	AOCI Balance				Effective				Effective Portion			AOCI Balance
		as of June 30,				Portion				Reclassified From			as of March 30,
		2012				Recorded In				AOCI Into			2013
						AOCI				Cost of  Sales
	Settled foreign currency forward contracts for the nine months ended March 30, 2013	$	(162	)		$	675			$	(513	)	$	—
	Unsettled foreign currency forward contracts	(497		)		3,319				—			2,822
	Total	$	(659	)		$	3,994			$	(513	)	$	2,822
	The Company does not enter into derivative instruments for trading or speculative purposes. The Company’s counterparties to the foreign currency forward contracts are major financial institutions. These institutions do not require collateral for the contracts and the Company believes that the risk of the counterparties failing to meet their contractual obligations is remote. As of March 29, 2014, the net amount of unrealized gain expected to be reclassified into earnings within the next 12 months is approximately $1.4 million. As of March 29, 2014, the Company does not have any foreign exchange contracts with credit-risk-related contingent features.

ACQUISITION

ACQUISITION	9 Months Ended
	Mar. 29, 2014
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	Acquisition
	On July 1, 2013, the Company acquired substantially all of the assets of Sabre Assembly & Manufacturing Co. of Texas (“Sabre”), a sheet metal fabrication company with facilities located in Juarez, Mexico. The acquisition of Sabre enables the Company to offer metal fabrication directly to its customers, in combination with plastic molding, PCB assembly, complete product assembly, design engineering and testing engineering services. Under the terms of the transaction, the assets acquired included manufacturing equipment, inventory, customer relationships and non-compete agreements with key employees. No debt or liabilities were assumed. The total cash payment of $6.0 million was funded through existing cash. The Company incurred approximately $50,000 of costs related to due diligence and closing this acquisition.
	The following table summarizes the fair values of the assets acquired as of the date of acquisition (in thousands):
		Fair Values
		At July 1, 2013
	Current Assets	$	777
	Fixed Assets	1,168
	Non-Compete Agreements	372
	Customer Relationships	1,970
	Goodwill	1,740
	Fair value of assets acquired	$	6,027
	The Sabre acquisition is accounted for using the acquisition method of accounting whereby the total purchase price is allocated to tangible and intangible assets and liabilities based on their fair values on the date of acquisition. The Company determines the purchase price allocations on the acquisition based on estimates of the fair values of the assets acquired. Goodwill recorded in connection with the above acquisition is primarily attributable to the synergies expected to arise after the Company’s acquisition of the business and the assembled workforce of the acquired business. The goodwill is not amortized for financial accounting purposes but is deductible for tax purposes over a 15-year period. The intangibles related to non-compete agreements and customer relationships will be amortized using the straight-line method over five and ten years, respectively. The carrying values of goodwill and intangibles reasonably approximate their fair values as of March 29, 2014.

SIGNIFICANT_ACCOUNTING_POLICIE1

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Mar. 29, 2014
Accounting Policies [Abstract]	'
Earnings Per Common Share	'
	Earnings Per Common Share
	Basic earnings per common share (EPS) is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing net income by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of equity awards were used to repurchase common shares at the average market price during the period. The computation of diluted EPS does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on EPS.
Derivatives	'
	Derivative Instruments and Hedging Activities
	The Company has entered into foreign currency forward contracts which are accounted for as cash flow hedges in accordance with ASC 815, Derivatives and Hedging. The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative's effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item.
	The Company transacts business in Mexico and is subject to the risk of foreign currency exchange rate fluctuations. The Company enters into foreign currency forward contracts to manage the majority of foreign currency fluctuations for Mexican peso denominated payroll, utility, tax, and accounts payable expenses. The foreign currency forward contracts have terms that are matched to the underlying transactions being hedged. As a result, these transactions fully offset the hedged risk and no ineffectiveness has been recorded.
	The Company's foreign currency forward contracts potentially expose the Company to credit risk to the extent the counterparties may be unable to meet the terms of the agreement. The Company minimizes such risk by seeking high quality counterparties. The Company's counterparties to the foreign currency forward contracts are major banking institutions. These institutions do not require collateral for the contracts, and the Company believes that the risk of the counterparties failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes.
Income Taxes	'
	Income Taxes
	We compute our interim income tax provision through the use of an estimated annual effective tax rate (ETR) applied to year-to-date operating results and specific events that are discretely recognized as they occur. In determining the estimated annual ETR, we analyze various factors, including projections of our annual earnings, taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, our ability to use tax credits and net operating loss carryforwards, and available tax planning alternatives. Discrete items, including the effect of changes in tax laws, tax rates, and certain circumstances with respect to valuation allowances or other unusual or non-recurring tax adjustments, are reflected in the period in which they occur as an addition to, or reduction from, the income tax provision, rather than included in the estimated annual ETR. Refer to Note 5 for further discussions.
	Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, as well as operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized.
	We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. To date, we have not incurred charges for interest or penalties in relation to the underpayment of income taxes. The tax years 1998 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject.
Recently Issued Accounting Standards	'
	Recently Issued Accounting Standards
	Management has assessed the potential impact of recently issued, but not yet effective, accounting standards and determined that the provisions are either not applicable to the Company, or are not anticipated to have a material impact on the consolidated financial statements.
Maximum Amount Of Income Tax Benefits Percentage Realized Upon Ultimate Settlement	50.00%

INVENTORIES_Tables

INVENTORIES (Tables)	9 Months Ended
	Mar. 29, 2014
Inventory Disclosure [Abstract]	'
Components of Inventories	'
	The components of inventories consist of the following (in thousands):
		29-Mar-14		29-Jun-13
	Finished goods	$	5,789	$	7,097
	Work-in-process	5,583		5,098
	Raw materials and supplies	34,714		32,469
		$	46,086	$	44,664

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	9 Months Ended
	Mar. 29, 2014
Earnings Per Share [Abstract]	'
Reconciliation of Denominator and Number of Antidilutive Common Share Awards not Included in Diluted Earnings Per Share Calculation	'
	These antidilutive securities occur when equity awards outstanding have an option price greater than the average market price for the period.
		Three Months Ended
		(in thousands, except per share information)
		March 29, 2014		March 30, 2013
	Net income	$	1,414	$	2,863
	Weighted average shares outstanding—basic	10,533		10,489
	Effect of dilutive common stock options	393		442
	Weighted average shares outstanding—diluted	10,926		10,931
	Earnings per share—basic	$	0.13	$	0.27
	Earnings per share—diluted	$	0.13	$	0.26
	Antidilutive options not included in diluted earnings per share	208		—
		Nine Months Ended
		(in thousands, except per share information)
		March 29, 2014		March 30, 2013
	Net income	$	6,233	$	10,186
	Weighted average shares outstanding—basic	10,523		10,488
	Effect of dilutive common stock options	397		400
	Weighted average shares outstanding—diluted	10,920		10,888
	Earnings per share—basic	$	0.59	$	0.97
	Earnings per share—diluted	$	0.57	$	0.94
	Antidilutive options not included in diluted earnings per share	208		—

SHAREBASED_COMPENSATION_Tables

SHARE-BASED COMPENSATION (Tables)	9 Months Ended
	Mar. 29, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	'
	The grant date fair value for the awards granted below were estimated using the Black Scholes option valuation method:
		July 31, 2013		July 25, 2012		January 26, 2012		27-Jul-11
	SARs Granted	213,166		210,666		32,000		184,666
	Strike Price	$	11.34	$	7.44	$	6.3	$	4.4
	Fair Value	$	4.67	$	3.71	$	3.08	$	2.2

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Mar. 29, 2014
Fair Value Disclosures [Abstract]	'
Assets and Liabilities Measured at Fair Value on Recurring Basis	'
	The following table summarizes the fair value of assets/(liabilities) of the Company’s derivatives that are required to be measured on a recurring basis as of March 29, 2014 and June 29, 2013 (in thousands):
		29-Mar-14
		Level 1		Level 2			Level 3		Total
									Fair Value
	Financial Assets:
	Foreign currency forward contracts	$	—	$	2,833		$	—	$	2,833
	Financial Liabilities:
	Foreign currency forward contracts	$	—	$	(59	)	$	—	$	(59	)
		29-Jun-13
		Level 1		Level 2			Level 3		Total
									Fair Value
	Financial Assets:
	Foreign currency forward contracts	$	—	$	2,429		$	—	$	2,429
	Financial Liabilities:
	Foreign currency forward contracts	$	—	$	(434	)	$	—	$	(434	)

DERIVATIVE_FINANCIAL_INSTRUMEN1

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Mar. 29, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Summerized Fair Value of Derivative Instruments in Consolidated Balance Sheets	'
	The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of March 29, 2014 and June 29, 2013 (in thousands):
				29-Mar-14				29-Jun-13
	Derivatives Designated as Hedging Instruments	Balance Sheet Location		Fair Value				Fair Value
	Foreign currency forward contracts	Other current assets		$	2,020			$	760
	Foreign currency forward contracts	Other long-term assets		$	813			$	1,669
	Foreign currency forward contracts	Other current liabilities		$	—			$	(145	)
	Foreign currency forward contracts	Other long-term liabilities		$	(59	)		$	(289	)
Gain (Loss) of Derivative Instruments in Statement of Operations	'
	The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended March 29, 2014 and March 30, 2013, respectively (in thousands):
	Derivatives Designated as Hedging Instruments	AOCI Balance				Effective				Effective Portion			AOCI Balance
		as of				Portion				Reclassified From			as of
		December 28,				Recorded In				AOCI Into			March 29,
		2013				AOCI				Cost of  Sales			2014
	Settled foreign currency forward contracts for the three months ended March 29, 2014	$	110			$	11			$	(121	)	$	—
	Unsettled foreign currency forward contracts	1,515				313				—			1,828
	Total	$	1,625			$	324			$	(121	)	$	1,828
	Derivatives Designated as Hedging Instruments	AOCI Balance				Effective				Effective Portion			AOCI Balance
		as of				Portion				Reclassified From			as of March 30,
		December 29,				Recorded In				AOCI Into			2013
		2012				AOCI				Cost of  Sales
	Settled foreign currency forward contracts for the three months ended March 30, 2013	$	(9	)		$	184			$	(175	)	$	—
	Unsettled foreign currency forward contracts	373				2,449				—			2,822
	Total	$	364			$	2,633			$	(175	)	$	2,822
	The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the nine months ended March 29, 2014 and March 30, 2013, respectively (in thousands):
	Derivatives Designated as Hedging Instruments	AOCI Balance				Effective				Effective Portion			AOCI Balance
		as of June 29,				Portion				Reclassified From			as of
		2013				Recorded In				AOCI Into			March 29,
						AOCI				Cost of  Sales			2014
	Settled foreign currency forward contracts for the nine months ended March 29, 2014	$	85			$	124			$	(209	)	$	—
	Unsettled foreign currency forward contracts	1,228				600				—			1,828
	Total	$	1,313			$	724			$	(209	)	$	1,828
	Derivatives Designated as Hedging Instruments	AOCI Balance				Effective				Effective Portion			AOCI Balance
		as of June 30,				Portion				Reclassified From			as of March 30,
		2012				Recorded In				AOCI Into			2013
						AOCI				Cost of  Sales
	Settled foreign currency forward contracts for the nine months ended March 30, 2013	$	(162	)		$	675			$	(513	)	$	—
	Unsettled foreign currency forward contracts	(497		)		3,319				—			2,822
	Total	$	(659	)		$	3,994			$	(513	)	$	2,822

ACQUISITION_Tables

ACQUISITION (Tables)	9 Months Ended
	Mar. 29, 2014
Business Combinations [Abstract]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	The following table summarizes the fair values of the assets acquired as of the date of acquisition (in thousands):
		Fair Values
		At July 1, 2013
	Current Assets	$	777
	Fixed Assets	1,168
	Non-Compete Agreements	372
	Customer Relationships	1,970
	Goodwill	1,740
	Fair value of assets acquired	$	6,027

Inventories_Components_Of_Inve

Inventories (Components Of Inventories) (Detail) (USD $)	Mar. 29, 2014	Jun. 29, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Finished goods	$5,789	$7,097
Work-in-process	5,583	5,098
Raw materials and supplies	34,714	32,469
Inventories	$46,086	$44,664

LongTerm_Debt_Narrative_Detail

Long-Term Debt (Narrative) (Detail) (USD $)	Mar. 29, 2014	Mar. 29, 2014	Mar. 29, 2014	Oct. 15, 2010	Mar. 29, 2014	Mar. 29, 2014	Mar. 29, 2014
		Line of Credit [Member]	Line of Credit [Member]	Wells Fargo Bank	Debt Instrument, Basis Spread on Variable Rate, Scenario One [Member]	Debt Instrument, Basis Spread on Variable Rate, Scenario Two [Member]	Debt Instrument, Basis Spread on Variable Rate, Scenario Three [Member]
		One-Month London Interbank Offered Rate [Member]	Federal Funds Rate [Member]		Line of Credit [Member]	Line of Credit [Member]	Line of Credit [Member]
					Fixed Rate [Member]	Fixed Rate [Member]	Fixed Rate [Member]
Debt Disclosure [Line Items]	'	'	'	'	'	'	'
Increase in revolving line of credit	'	'	'	$30,000,000	'	'	'
Variable rate on line of credit facility (percent)	'	1.50%	1.50%	'	1.75%	2.00%	2.25%
Additional availability of line of credit	$30,000,000	'	'	'	'	'	'

Income_Taxes_Narrative_Detail

Income Taxes (Narrative) (Detail) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Mar. 29, 2014
Income Tax Disclosure [Abstract]	'
Foreign tax credits related to future repatriations of earnings	$9.90
Gross potential research and development (R&D) tax credit	5
Unrecognized tax benefits associated with federal tax credits	3.1
Deferred Income Tax Expense (Benefit)	$1.90

Earnings_Per_Share_Reconciliat

Earnings Per Share (Reconciliation Of Denominator And Number Of Antidilutive Common Share Awards Not Included In Diluted Earnings Per Share Calculation) (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Net income	$1,414	$2,863	$6,233	$10,186
Weighted average shares outstanding - basic	10,533	10,489	10,523	10,488
Effect of dilutive common stock options (Shares)	393	442	397	400
Weighted average shares outstanding - Diluted	10,926	10,931	10,920	10,888
Earnings per share - basic (in dollars per share)	$0.13	$0.27	$0.59	$0.97
Earnings per share - diluted (in dollars per share)	$0.13	$0.26	$0.57	$0.94
Antidilutive options not included in diluted earnings per share (Shares)	208	0	208	0

ShareBased_Compensation_Narrat

Share-Based Compensation (Narrative) (Detail) (USD $)	0 Months Ended	1 Months Ended			3 Months Ended		9 Months Ended
	Jul. 25, 2012	Jul. 31, 2013	Jan. 26, 2012	Jul. 27, 2011	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	'	'	'	'	$1,100,000	'	$1,100,000	'
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	'	'	'	'	'	'	'1 year 11 months 12 days	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	'	'	'	'	'	'	'	7,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	'	'	'	'	0	'	0	'
Stock Appreciation Rights (SARs) [Member]	'	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	210,666	213,166	32,000	184,666	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$7.44	$11.34	$6.30	$4.40	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$3.71	$4.67	$3.08	$2.20	'	'	'	'
Allocated Share-based Compensation Expense	'	'	'	'	$148,000	$222,000	$483,000	$647,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	'	'	'	'	'	'	30,000	'
Employee Stock Option [Member]	'	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	'	'	'	'	'	'	19,930	'

Commitments_And_Contingencies_

Commitments And Contingencies (Narrative) (Detail) (USD $)	Mar. 29, 2014	Jun. 29, 2013	Mar. 29, 2014
			Maximum
Purchase Commitment, Excluding Long-term Commitment [Line Items]	'	'	'
Terms of lease agreements	'	'	'10 years
Warranty reserve	$8,000	$9,000	'

Fair_Value_Measurements_Assets

Fair Value Measurements (Assets And Liabilities Measured At Fair Value On Recurring Basis) (Detail) (USD $)	Mar. 29, 2014	Jun. 29, 2013
In Thousands, unless otherwise specified
Level 1	'	'
Fair Value Disclosures [Line Items]	'	'
Foreign currency forward contracts, Financial Assets	$0	$0
Foreign currency forward contracts, Financial Liabilities	0	0
Level 2	'	'
Fair Value Disclosures [Line Items]	'	'
Foreign currency forward contracts, Financial Assets	2,833	2,429
Foreign currency forward contracts, Financial Liabilities	-59	-434
Level 3	'	'
Fair Value Disclosures [Line Items]	'	'
Foreign currency forward contracts, Financial Assets	0	0
Foreign currency forward contracts, Financial Liabilities	0	0
Total Fair Value	'	'
Fair Value Disclosures [Line Items]	'	'
Foreign currency forward contracts, Financial Assets	2,833	2,429
Foreign currency forward contracts, Financial Liabilities	($59)	($434)

Recovered_Sheet1

Derivative Financial Instruments (Narrative) (Detail) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'	'	'
Outstanding foreign currency forward contracts	$67.40	'	$67.40	'
Contract maturity date	'	'	28-Jun-17	'
Foreign currency forward contracts	5	10.9	15.2	21.5
Foreign currency forward contracts settled	5.7	5.8	17.6	17
Net amount of existing losses expected to be reclassified into earnings within the next 12 months	$1.40	'	$1.40	'

Recovered_Sheet2

Derivative Financial Instruments (Summarized Fair Value Of Derivative Instruments In Consolidated Balance Sheets) (Detail) (USD $)	Mar. 29, 2014	Jun. 29, 2013
In Thousands, unless otherwise specified
Other Current Assets	'	'
Derivative Instruments [Line Items]	'	'
Foreign currency forward contracts, Fair Value	$2,020	$760
Other Long Term Assets	'	'
Derivative Instruments [Line Items]	'	'
Foreign currency forward contracts, Fair Value	813	1,669
Other Current Liabilities	'	'
Derivative Instruments [Line Items]	'	'
Derivative Liability, Fair Value, Amount Not Offset Against Collateral	0	-145
Other Long Term Liabilities	'	'
Derivative Instruments [Line Items]	'	'
Derivative Liability, Fair Value, Amount Not Offset Against Collateral	($59)	($289)

Derivative_Financial_Instrumen2

Derivative Financial Instruments (Gain (Loss) Of Derivative Instruments In Statement Of Operations) (Detail) (Designated As Hedging Instrument, USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013	Mar. 29, 2014	Mar. 30, 2013
Derivative Instruments [Line Items]	'	'	'	'	'	'
Derivative Instruments Gain Loss Effective Portion Recorded In AOCI	324,000	2,633,000	724,000	3,994,000	'	'
Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]	'	'	'	'	'	'
AOCI Balance	$1,625	$364	$1,313	($659)	$1,828	$2,822
Effective Portion Recorded In AOCI	-121	-175	-209	-513	'	'
Settled Foreign Currency Forward Contracts	'	'	'	'	'	'
Derivative Instruments [Line Items]	'	'	'	'	'	'
Derivative Instruments Gain Loss Effective Portion Recorded In AOCI	11,000	184,000	124,000	675,000	'	'
Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]	'	'	'	'	'	'
AOCI Balance	110	-9	85	-162	0	0
Effective Portion Recorded In AOCI	-121	-175	-209	-513	'	'
Unsettled Foreign Currency Forward Contracts	'	'	'	'	'	'
Derivative Instruments [Line Items]	'	'	'	'	'	'
Change in Unrealized Gain (Loss) on Foreign Currency	313,000	2,449,000	600,000	3,319,000	'	'
Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]	'	'	'	'	'	'
AOCI Balance	$1,515	$373	$1,228	($497)	$1,828	$2,822
Change in Unrealized Gain (Loss) of Foreign Currency Effective Portion Reclassified From AOCI Into Cost of Sales	0	0	0	0	'	'

Acquisition_Detail

Acquisition (Detail) (USD $)	9 Months Ended
	Mar. 29, 2014	Jul. 01, 2013	Jun. 29, 2013
Business Combinations [Abstract]	'	'	'
Payments to Acquire Businesses, Gross	$6,000,000	'	'
Business Combination, Acquisition Related Costs	50,000	'	'
Business Acquisition [Line Items]	'	'	'
Current Assets	'	777,000	'
Fixed Assets	'	1,168,000	'
Non-Compete Agreements	'	372,000	'
Customer Relationships	'	1,970,000	'
Goodwill	1,740,000	1,740,000	0
Fair value of assets acquired	'	$6,027,000	'